IBDEI1GT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24485,1,3,0)
 ;;=3^Herpes Simplex, Lip
 ;;^UTILITY(U,$J,358.3,24485,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,24485,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,24486,0)
 ;;=B00.2^^121^1221^114
 ;;^UTILITY(U,$J,358.3,24486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24486,1,3,0)
 ;;=3^Herpesvirial gingivostomatitis and pharyngotonsillitis
 ;;^UTILITY(U,$J,358.3,24486,1,4,0)
 ;;=4^B00.2
 ;;^UTILITY(U,$J,358.3,24486,2)
 ;;=^5000469
 ;;^UTILITY(U,$J,358.3,24487,0)
 ;;=B02.9^^121^1221^111
 ;;^UTILITY(U,$J,358.3,24487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24487,1,3,0)
 ;;=3^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,24487,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,24487,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,24488,0)
 ;;=A60.01^^121^1221^115
 ;;^UTILITY(U,$J,358.3,24488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24488,1,3,0)
 ;;=3^Herpetic Infect of Penis
 ;;^UTILITY(U,$J,358.3,24488,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,24488,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,24489,0)
 ;;=A60.04^^121^1221^116
 ;;^UTILITY(U,$J,358.3,24489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24489,1,3,0)
 ;;=3^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,24489,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,24489,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,24490,0)
 ;;=B01.9^^121^1221^113
 ;;^UTILITY(U,$J,358.3,24490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24490,1,3,0)
 ;;=3^Herpes, varicella
 ;;^UTILITY(U,$J,358.3,24490,1,4,0)
 ;;=4^B01.9
 ;;^UTILITY(U,$J,358.3,24490,2)
 ;;=^5000487
 ;;^UTILITY(U,$J,358.3,24491,0)
 ;;=B00.3^^121^1221^112
 ;;^UTILITY(U,$J,358.3,24491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24491,1,3,0)
 ;;=3^Herpes, Meningitis
 ;;^UTILITY(U,$J,358.3,24491,1,4,0)
 ;;=4^B00.3
 ;;^UTILITY(U,$J,358.3,24491,2)
 ;;=^5000470
 ;;^UTILITY(U,$J,358.3,24492,0)
 ;;=B00.9^^121^1221^109
 ;;^UTILITY(U,$J,358.3,24492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24492,1,3,0)
 ;;=3^Herpes NEC
 ;;^UTILITY(U,$J,358.3,24492,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,24492,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,24493,0)
 ;;=B39.2^^121^1221^120
 ;;^UTILITY(U,$J,358.3,24493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24493,1,3,0)
 ;;=3^Histoplasmosis,Pulmonary
 ;;^UTILITY(U,$J,358.3,24493,1,4,0)
 ;;=4^B39.2
 ;;^UTILITY(U,$J,358.3,24493,2)
 ;;=^5000634
 ;;^UTILITY(U,$J,358.3,24494,0)
 ;;=B39.9^^121^1221^118
 ;;^UTILITY(U,$J,358.3,24494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24494,1,3,0)
 ;;=3^Histoplasmosis NEC
 ;;^UTILITY(U,$J,358.3,24494,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,24494,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,24495,0)
 ;;=Z21.^^121^1221^98
 ;;^UTILITY(U,$J,358.3,24495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24495,1,3,0)
 ;;=3^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,24495,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,24495,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,24496,0)
 ;;=B20.^^121^1221^97
 ;;^UTILITY(U,$J,358.3,24496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24496,1,3,0)
 ;;=3^HIV + (Symptomatic)/AIDS
 ;;^UTILITY(U,$J,358.3,24496,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,24496,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,24497,0)
 ;;=A63.0^^121^1221^122
 ;;^UTILITY(U,$J,358.3,24497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24497,1,3,0)
 ;;=3^Human Papillomavirus infection
 ;;^UTILITY(U,$J,358.3,24497,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,24497,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,24498,0)
 ;;=Z91.19^^121^1221^121
 ;;^UTILITY(U,$J,358.3,24498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24498,1,3,0)
 ;;=3^History of past non-compliance
